Notably, although NKX2-1 was overall strongly expressed in advanced lung tumor stages, small tumor foci presumably representing early lesions often showed a heterogeneous and overall reduced nuclear NKX2-1 immunoreactivity (Figure S7C). This evidence concerns the gene NKX2-1 and neoplasm.